85 related articles for article (PubMed ID: 21192930)
1. Atorvastatin and Aβ(1-40): not as simple as cholesterol reduction in brain and relevance to Alzheimer disease.
Butterfield DA
Exp Neurol; 2011 Mar; 228(1):15-8. PubMed ID: 21192930
[No Abstract] [Full Text] [Related]
2. Inhibition of tau hyperphosphorylation and beta amyloid production in rat brain by oral administration of atorvastatin.
Lu F; Li X; Suo AQ; Zhang JW
Chin Med J (Engl); 2010 Jul; 123(14):1864-70. PubMed ID: 20819569
[TBL] [Abstract][Full Text] [Related]
3. The influence of simvastatin, atorvastatin and high-cholesterol diet on acetylcholinesterase activity, amyloid beta and cholesterol synthesis in rat brain.
Cibickova L; Hyspler R; Micuda S; Cibicek N; Zivna H; Jun D; Ticha A; Brcakova E; Palicka V
Steroids; 2009 Jan; 74(1):13-9. PubMed ID: 18817797
[TBL] [Abstract][Full Text] [Related]
4. Statin therapy for Alzheimer's disease: will it work?
Petanceska SS; DeRosa S; Olm V; Diaz N; Sharma A; Thomas-Bryant T; Duff K; Pappolla M; Refolo LM
J Mol Neurosci; 2002; 19(1-2):155-61. PubMed ID: 12212773
[TBL] [Abstract][Full Text] [Related]
5. Atorvastatin for the treatment of mild to moderate Alzheimer disease: preliminary results.
Sparks DL; Sabbagh MN; Connor DJ; Lopez J; Launer LJ; Browne P; Wasser D; Johnson-Traver S; Lochhead J; Ziolwolski C
Arch Neurol; 2005 May; 62(5):753-7. PubMed ID: 15883262
[TBL] [Abstract][Full Text] [Related]
6. Development of retro-inverso peptides as anti-aggregation drugs for β-amyloid in Alzheimer's disease.
Matharu B; El-Agnaf O; Razvi A; Austen BM
Peptides; 2010 Oct; 31(10):1866-72. PubMed ID: 20633587
[TBL] [Abstract][Full Text] [Related]
7. [Effective cholesterol and triglyceride lowering with atorvastatin].
Internist (Berl); 1996 Aug; 37(8 Suppl Effektive):1-8. PubMed ID: 9404527
[No Abstract] [Full Text] [Related]
8. ß-amyloid-related peptides potentiate K+-evoked glutamate release from adult rat hippocampal slices.
Kabogo D; Rauw G; Amritraj A; Baker G; Kar S
Neurobiol Aging; 2010 Jul; 31(7):1164-72. PubMed ID: 18819729
[TBL] [Abstract][Full Text] [Related]
9. Plasma levels of beta-amyloid(1-40), beta-amyloid(1-42), and total beta-amyloid remain unaffected in adult patients with hypercholesterolemia after treatment with statins.
Höglund K; Wiklund O; Vanderstichele H; Eikenberg O; Vanmechelen E; Blennow K
Arch Neurol; 2004 Mar; 61(3):333-7. PubMed ID: 15023808
[TBL] [Abstract][Full Text] [Related]
10. Randomization of amyloid-β-peptide(1-42) conformation by sulfonated and sulfated nanoparticles reduces aggregation and cytotoxicity.
Saraiva AM; Cardoso I; Saraiva MJ; Tauer K; Pereira MC; Coelho MA; Möhwald H; Brezesinski G
Macromol Biosci; 2010 Oct; 10(10):1152-63. PubMed ID: 20480510
[TBL] [Abstract][Full Text] [Related]
11. Cholesterol modulates amyloid beta-peptide's membrane interactions.
Eckert GP; Kirsch C; Leutz S; Wood WG; Müller WE
Pharmacopsychiatry; 2003 Sep; 36 Suppl 2():S136-43. PubMed ID: 14574628
[TBL] [Abstract][Full Text] [Related]
12. Leaf and stem of Vitis amurensis and its active components protect against amyloid β protein (25-35)-induced neurotoxicity.
Jeong HY; Kim JY; Lee HK; Ha do T; Song KS; Bae K; Seong YH
Arch Pharm Res; 2010 Oct; 33(10):1655-64. PubMed ID: 21052941
[TBL] [Abstract][Full Text] [Related]
13. Aβ40(L17A/F19A) mutant diminishes the aggregation and neurotoxicity of Aβ40.
Chen YR; Huang HB; Lo CJ; Wang CC; Su CL; Liu HT; Shiao MS; Lin TH; Chen YC
Biochem Biophys Res Commun; 2011 Feb; 405(1):91-5. PubMed ID: 21216230
[TBL] [Abstract][Full Text] [Related]
14. The HMG-CoA reductase inhibitor, atorvastatin, attenuates the effects of acute administration of amyloid-beta1-42 in the rat hippocampus in vivo.
Clarke RM; O'Connell F; Lyons A; Lynch MA
Neuropharmacology; 2007 Jan; 52(1):136-45. PubMed ID: 16920163
[TBL] [Abstract][Full Text] [Related]
15. Atorvastatin treatment in a dog preclinical model of Alzheimer's disease leads to up-regulation of haem oxygenase-1 and is associated with reduced oxidative stress in brain.
Butterfield DA; Barone E; Di Domenico F; Cenini G; Sultana R; Murphy MP; Mancuso C; Head E
Int J Neuropsychopharmacol; 2012 Aug; 15(7):981-7. PubMed ID: 21767440
[TBL] [Abstract][Full Text] [Related]
16. Cholesterol trafficking and amyloid beta peptides.
Wood WG; Igbavboa U
Pharmacopsychiatry; 2003 Sep; 36 Suppl 2():S144-8. PubMed ID: 14574629
[TBL] [Abstract][Full Text] [Related]
17. Decreased macrophage paraoxonase 2 expression in patients with hypercholesterolemia is the result of their increased cellular cholesterol content: effect of atorvastatin therapy.
Rosenblat M; Hayek T; Hussein K; Aviram M
Arterioscler Thromb Vasc Biol; 2004 Jan; 24(1):175-80. PubMed ID: 14592851
[TBL] [Abstract][Full Text] [Related]
18. Changes in cognition and amyloid-β processing with long term cholesterol reduction using atorvastatin in aged dogs.
Murphy MP; Morales J; Beckett TL; Astarita G; Piomelli D; Weidner A; Studzinski CM; Dowling AL; Wang X; Levine H; Kryscio RJ; Lin Y; Barrett E; Head E
J Alzheimers Dis; 2010; 22(1):135-50. PubMed ID: 20847439
[TBL] [Abstract][Full Text] [Related]
19. [Effects of Valeriana amurensis on the expressions of beta-APP, Abeta(1-40) and caspase-3 in Alzheimer's disease model rat's brain].
Zuo YM; Zhang ZL; Wang QH; Xie N; Kuang HX
Zhong Yao Cai; 2010 Feb; 33(2):233-6. PubMed ID: 20575418
[TBL] [Abstract][Full Text] [Related]
20. Systemic evaluation of gene expression changes in major target organs induced by atorvastatin.
Kato N; Liang YQ; Ochiai Y; Jesmin S
Eur J Pharmacol; 2008 Apr; 584(2-3):376-89. PubMed ID: 18295756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
